Definitive Healthcare Corp. (DH) News
Filter DH News Items
DH News Results
Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
DH News Highlights
- For DH, its 30 day story count is now at 6.
- Over the past 4 days, the trend for DH's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
Latest DH News From Around the Web
Below are the latest news stories about DEFINITIVE HEALTHCARE CORP that investors may wish to consider to help them evaluate DH as an investment opportunity.
Definitive Healthcare to Present at the Raymond James 2023 Institutional Investors ConferenceFRAMINGHAM, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Chief Financial Officer, Rick Booth, will present at the Raymond James 2023 Institutional Investors Conference. The Definitive Healthcare presentation is scheduled for Tuesday, March 7, 2023, at 2:50 p.m. Eastern Time. A live webcast of the presentation will be available on the Events page of th |
Macro Headwinds Dragged Definitive Healthcare Corp. (DH) in Q4Baron Funds, an investment management company, released its “Baron Discovery Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. The fund’s performance was flat compared to the Russell 2000 Growth Index in the fourth quarter. The fund (institutional shares) returned 0.22% compared to the benchmark return of 4.13%. The fund […] |
Definitive Healthcare Corp. (NASDAQ:DH) Q4 2022 Earnings Call TranscriptDefinitive Healthcare Corp. (NASDAQ:DH) Q4 2022 Earnings Call Transcript February 23, 2023 Operator: Ladies and gentlemen, greetings, and welcome to the Definitive Healthcare Fourth Quarter 2022 Earnings Conference Call. At this time, all participant lines are in a listen only mode. A brief question-and-answer session will follow the formal presentation. As a reminder, this conference […] |
Shareholders in Definitive Healthcare (NASDAQ:DH) are in the red if they invested a year agoInvestors can approximate the average market return by buying an index fund. While individual stocks can be big... |
Q4 2022 Definitive Healthcare Corp Earnings CallQ4 2022 Definitive Healthcare Corp Earnings Call |
How Much Upside is Left in Definitive Healthcare Corp. (DH)? Wall Street Analysts Think 29.75%The consensus price target hints at a 29.8% upside potential for Definitive Healthcare Corp. (DH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. |
Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2022Fourth quarter revenue grew 31% year-over-year to $60.6 million Full year 2022 revenue grew 34% to $222.7 million FRAMINGHAM, Mass., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter and full year ended December 31, 2022. Fourth Quarter 2022 Financial Highlights: Revenue was $60.6 million, an increase of 31% from $46.3 mi |
Definitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2022 Financial Results Conference Call and WebcastFRAMINGHAM, Mass., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its fourth quarter and full year ended December 31, 2022 financial results will be released on Thursday, February 23, 2023, after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company’s financial results. A live audio webcast of the e |
Definitive Healthcare greatly expands all-payor medical and prescription claims coverage60% increase in Atlas Prescription Claims and a significant increase in Atlas All-Payor Claims provides clients with a more in-depth and holistic look at patient care across the healthcare continuumFRAMINGHAM, Mass., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced expanded coverage of its prescription and all-payor medical claims data in the Atlas Dataset. The company’s Atlas Prescription Claims cover |
Definitive Healthcare introduces the Atlas DatasetIncludes reference & affiliation data, all-payor & prescription claims, and medical experts to help clients analyze the healthcare market from nearly any vantage pointFRAMINGHAM, Mass., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today introduced its Atlas Dataset, which provides the foundation for the company’s healthcare commercial intelligence and powers Definitive Healthcare’s existing products, analytics, an |